chr19-14151054-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 1P and 10B. PP2BP4_ModerateBS1BS2
The NM_014921.5(ADGRL1):c.4229C>T(p.Ala1410Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000141 in 1,490,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014921.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRL1 | NM_014921.5 | c.4229C>T | p.Ala1410Val | missense_variant | 23/23 | ENST00000361434.8 | NP_055736.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRL1 | ENST00000361434.8 | c.4229C>T | p.Ala1410Val | missense_variant | 23/23 | 1 | NM_014921.5 | ENSP00000355328.2 |
Frequencies
GnomAD3 genomes AF: 0.0000597 AC: 9AN: 150828Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000288 AC: 3AN: 104176Hom.: 0 AF XY: 0.0000183 AC XY: 1AN XY: 54766
GnomAD4 exome AF: 0.00000896 AC: 12AN: 1339278Hom.: 0 Cov.: 45 AF XY: 0.0000107 AC XY: 7AN XY: 655182
GnomAD4 genome AF: 0.0000597 AC: 9AN: 150828Hom.: 0 Cov.: 31 AF XY: 0.0000272 AC XY: 2AN XY: 73636
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.4244C>T (p.A1415V) alteration is located in exon 24 (coding exon 23) of the ADGRL1 gene. This alteration results from a C to T substitution at nucleotide position 4244, causing the alanine (A) at amino acid position 1415 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at